International Journal of Dentistry

International Journal of Dentistry / 2017 / Article

Research Article | Open Access

Volume 2017 |Article ID 6185395 |

Pirjo Pärnänen, Ali Nawaz, Timo Sorsa, Jukka Meurman, Pirjo Nikula-Ijäs, "The Effect of Fermented Lingonberry Juice on Candida glabrata Intracellular Protein Expression", International Journal of Dentistry, vol. 2017, Article ID 6185395, 6 pages, 2017.

The Effect of Fermented Lingonberry Juice on Candida glabrata Intracellular Protein Expression

Academic Editor: Vincent Everts
Received08 Jan 2017
Accepted28 Feb 2017
Published30 Mar 2017


Lingonberries have a long traditional use in treating fungal infections on mucosal membranes, but very little is known about the exact antifungal mechanisms. We tested the effects of fermented lingonberry juice on Candida glabrata intracellular protein expression. A Candida glabrata clinical strain was grown in the presence of fermented lingonberry juice (FLJ). Also the effect of lowered pH was tested. Intracellular protein expression levels were analyzed by the 2D-DIGE method. Six proteins detected with ≥1.5-fold lowered expression levels from FLJ treated cells were further characterized with LC-MS/MS. Heat shock protein 9/12 and redoxin were identified with peptide coverage/scores of 68/129 and 21/26, respectively. Heat shock protein 9/12 had an oxidized methionine at position 56. We found no differences in protein expression levels at pH 3.5 compared to pH 7.6. These results demonstrate that FLJ exerts an intracellular stress response in Candida glabrata, plausibly impairing its ability to express proteins related to oxidative stress or maintaining cell wall integrity.

1. Introduction

Oral yeast infections are most commonly caused by Candida albicans. Predisposing factors include the use of broad-spectrum antibiotics, dry mouth, or ill-fitting dental prostheses. The second most common yeast Candida glabrata (C. glabrata) is an opportunistic fungal pathogen and causes serious infections, particularly in the immunocompromised patients [1, 2]. C. glabrata’s resistance to the most commonly used antifungals, the azoles, is considered to be innate or acquired [3]. Additionally, C. glabrata biofilms are more resistant to antifungals [4]. C. glabrata has been known to damage the host’s immune responses by inducing proinflammatory cytokines [5] as well as modulating proteolysis [6, 7]. The search for new antifungal agents leads us to test the effects of fermented lingonberry juice on C. glabrata.

There are a few studies on the effects of lingonberries on C. albicans and other oral microbial species, but the effects on C. glabrata have not been tested. Most of these studies concern antimicrobial, biofilm formation, or adhesion/coaggregation properties [810]. The effects on intracellular protein expression by C. glabrata have not been addressed with lingonberry. Lingonberries are rich in phenolic compounds, which are thought to be beneficial to health. The antimicrobial fractions from lingonberries have been partly solved, but the chemical complexity of the berry material makes it difficult to precisely pinpoint the active ingredient. The aim of our study was to evaluate the effect of fermented lingonberry juice (FLJ) on C. glabrata intracellular protein expression.

2. Materials and Methods

2.1. Yeast Growing and Fermented Lingonberry Juice Treatment

A clinical C. glabrata (T-1639) from a patient from Helsinki University Central Hospital was cultured on a Sabouraud dextrose agar plate (SDA plate, Lab M, Bury, UK) for 18 h at 37°C. Two separate colonies were cultured in YPG (0.5% yeast extract, 1% peptone, and 0.5% glucose) o/n at 37°C. The amount of yeast cells was adjusted to 0.6 × 107 CFU/mL. Fermented and lyophilized lingonberry juice was prepared as described by Pärnänen [11]. Three sets of cultures were made: 9 mL YPG pH 7.6 + 1 mL of yeast suspension, 9 mL of YPG pH 3.5 + 1 mL of yeast suspension, and 9 mL YPG pH 7.6 + 1 mL of yeast suspension + 1.05 g freeze-dried FLJ (final pH 3.5). To retrieve enough yeast cells for further protein assays, we found that 1.05 g/10 mL of lingonberry powder and 2.5 h treatment time were appropriate to inhibit 50% of growth. After 2.5 h incubation at 37°C, the yeast cells were washed two times with 10 mL MQ (4000, 10 min, RT). To see if the treatments had a long-term effect, the remaining pellets were suspended into 9 mL of YPG, pH 7.6, and cultured on SDA plates for 18 h at 37°C (vertical shaker, slow speed). After the incubation, the cells were washed two times with 10 mL MQ. The cell pellets were suspended in 1x lysis buffer (8 M urea; 4% CHAPS; 30 mM Tris, pH 8.0) and broken with 0.5 mm glass beads 18 times for 30 s with 30 s intervals (10 min pause on ice after every 6 cycles). The suspension was filtered with a 0.22 μm filter (Millipore).

2.2. 2D-DIGE

The suspensions were purified using 2D Clean-Up Kit (GE Healthcare, Uppsala, Sweden) and quantified with 2D Quant Kit (GE Healthcare, Uppsala, Sweden) according to manufacturer’s recommendations. The samples were labelled with CyDye DIGE Fluors (minimal dyes) Cy2, Cy3, and Cy5 (GE Healthcare, Buckinghamshire, UK) according to manufacturer’s instructions (Table 1). Isoelectric focusing was performed (IPGphor, GE Healthcare) with Immobiline DryStrip, pH 4–7 (GE Healthcare), with values of 150 V 3 h, 300 V 3 h, 1000 V 6 h, 8000 V 1 h 15 min, and 8000 V 3 h 45 min. 2D electrophoresis was performed with values of 150 V, 30 mA, 2 W for 1 h and 500 V, 500 mA, 45 W for 4 h. Three gels were run/colony (total six gels). The gels were scanned with Typhoon 4044, and analyses of the expression level changes of proteins were made with DeCyder 2D Differential Analysis Software (GE Healthcare). All gels were silver-stained after laser scanning. Protein spots exhibiting ≥ 1.5-fold alteration in expression were cut out from the silver-stained gels and stored at −20°C.

Gels 1 & 4pH 3.5Cy3

Gels 2 & 5pH 3.5Cy5
pH 7.6Cy3

Gels 3 & 6pH 7.6Cy3

2.3. LC-MS/MS

Silver-stained protein bands were “in-gel” digested. Cysteine bonds were reduced with 0.045 M dithiothreitol (#D0632, Sigma-Aldrich, USA) for 20 min at 37°C and alkylated with 0.1 M iodoacetamide (#57670 Fluka, Sigma-Aldrich, USA) at room temperature. Samples were digested by adding 0.75 μg trypsin (Sequencing Grade Modified Trypsin, V5111, Promega). After digestion, peptides were purified with C18 microspin columns (Harvard Apparatus) according to manufacturer’s protocol and redissolved in 30 μL.

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) analysis was carried out on an EASY-nLC (Thermo Fisher Scientific, Germany) connected to a Velos Pro Orbitrap Elite hybrid mass spectrometer (Thermo Fisher Scientific, Germany) with nanoelectrospray ion source (Thermo Fisher Scientific, Germany). The LC-MS/MS samples were separated using a two-column setup consisting of a 2 cm C18-A1 trap column (Thermo Fisher Scientific, Germany), followed by a 10 cm C18-A2 analytical column (Thermo Fisher Scientific, Germany). The linear separation gradient consisted of 5% buffer B in 5 min, 35% buffer B in 60 min, 80% buffer B in 5 min, and 100% buffer B in 10 min at a flow rate of 0,3 μL/min (buffer A: 0,1% TFA in 1% acetonitrile; buffer B: 0,1% TFA acid in 98% acetonitrile). 6 μL of sample was injected per LC-MS/MS run and analyzed. Full MS scan was acquired with a resolution of 60 000 at normal mass range in the orbitrap analyzer. The method was set to fragment the 20 most intense precursor ions with CID (energy 35). Data was acquired using LTQ Tune software.

Acquired MS2 scans were searched against UniProt Candida glabrata protein database using the SEQUEST search algorithms in Thermo Proteome Discoverer. Allowed error for the precursor ions was 15 ppm and mass error for the fragment was 0.8 Da. A static residue modification parameter was set for carbamidomethyl +57,021 Da (C) of cysteine residue. Methionine oxidation was set as dynamic modification +15,995 Da (M). Only full-tryptic peptides were allowed for scoring and maximum of 1 missed cleavage was considered.

3. Results

2D-DIGE gel is shown in Figure 1(a). The silver-stained gel is shown in Figure 1(b). The results from the two separate C. glabrata T-1639 colonies were similar. There were no significant effects of pH on the intracellular protein expression levels at pH 3.5 compared to pH 7.6 (gels 2 and 5), and because of this we analyzed the rest of the gels as quadruplicate repetitions with Student’s -test and one-way ANOVA and achieved significant differences in six proteins. After FLJ treatment, a great number of the hundreds of the intracellular proteins showed elevated or decreased expression levels compared to the control, but mostly the alterations were nonsignificant. Six proteins showed ≥1.5-fold decreased significant expressions. Results from the UniProt protein database search are shown in Table 2. The peptide coverage (%)/scores in one sample were so low (sample 6) that we could not identify the protein. In sample 5, the coverage/score was 12.5/7.7 compared to C. glabrata CBS138 glyceraldehyde-3-phosphate dehydrogenase-2 (GADPH-2). Samples 3 and 4 showed coverage/scores of 13.1/11.9 and 13.8/13.1 subsequently for C. glabrata CBS138 adenylate kinase. Sample 2 gave coverage/score of 20.6/25.6 and was matched with redoxin Q6FIU4 (Figure 2.). Sample 1 showed the highest values of 68/129 and has methionine oxidation at position 56 and it matches C. glabrata CBS138 heat shock protein 9/12 (HSP 9/12) (Q6FPF6) (Figure 2.).

AccessionDescriptionScoreCoverage# proteins# unique peptides# peptides# PSMs# AAsMW [kDa]Calc. pI

Sample 1Q6FPF6Strain CBS138 chromosome J complete sequence OS = Candida glabrata (strain ATCC 2001/CBS 138/JCM 3761/NBRC 0622/NRRL Y-65) GN = CAGL0J04202 g PE = 4 SV = 1−[Q6FPF6_CANGA]129,0167,961884310311,25,02
A2Sequence# PSMs# proteins# protein groupsProtein group accessionsModificationsΔCnXCorrProbability
HighGVAQGMHDSAQK1011Q6FPF6M6 (oxidation)0,00003,100,00
HighFQGEENKGVAQGMHDSAQK111Q6FPF6M13 (oxidation)0,00002,810,00

Sample 2Q6FIU4Strain CBS138 chromosome M complete sequence OS = Candida glabrata (strain ATCC 2001/CBS 138/JCM 3761/NBRC 0622/NRRL Y-65) GN = CAGL0M11704 g PE = 4 SV = 1−[Q6FIU4_CANGA]25,5720,57144917518,95,53
A2Sequence# PSMs# proteins# protein groupsProtein group accessionsModificationsΔCnXCorrProbability

4. Discussion

The aim of this study was to find new means to prevent candidosis, especially C. glabrata- related infections, by identifying potential candidate proteins which are downregulated due to the treatment with FLJ and to address their roles in C. glabrata cell viability and upregulation of oral biofilm formation and thickening subsequently leading to candidosis and related inflammation. Among the studied proteins, five were significantly downregulated and identified with LC-MS/MS. Thus downregulation may eventually cause reduction in their pathological potential to induce disease. The results from our study demonstrate that FLJ exerts anticandidal effects that might have clinical implications.

The inhibition of the C. glabrata growth by FLJ was pronounced, and the amount of FLJ as well as treatment time needed to be minimized to obtain enough protein for the analyses. In our study, there was no significant difference in intracellular protein expression at pH 3.5 compared to pH 7.6. Indeed, Ullah et al. [12] have shown that C. glabrata is capable of maintaining more stable intracellular pH compared to S. cerevisiae when challenged with low extracellular pH. Interestingly, FLJ treatment did have a long-term effect on C. glabrata intracellular protein expression.

In fact, here we demonstrate FLJ-dependent downregulation of GADPH-2 in C. glabrata. GADPH is involved in the carbohydrate processing and one of the early steps in glycolysis. In S. cerevisiae, GADPH activity is associated with exponentially growing cells [13]. Azole resistance associated with petite mutations in C. glabrata [14] revealed alterations of intracellular proteins, for example, GADPH-2 and HSP 12.

Adenylate kinase catalyzes the formation of ADP [15]. FLJ caused downregulation of C. glabrata adenylate kinase expression, implicating that the ADP availability to be utilized in the oxidative phosphorylation can be diminished, and this may also impair the energy requirements essential for the pathological process leading to candidosis.

In our study, the expressions of HSP 9/12 and redoxin were lowered to the largest degree. HSP 9 from Saccharomyces pombe is related to stress response and HSP 12 from Saccharomyces cerevisiae maintains cell stability under stress conditions [16]. Redoxin is associated with reduced oxidative stress [17]. In our study, the methionine oxidation of HSP 9/12 after the FLJ- treatment also implies that some oxidation-promoting events on the cell wall have occurred. It has been shown that increased antioxidant proteins of C. albicans, for example, alkyl hydroperoxide reductase, thioredoxin peroxidase, and thioredoxin [18], and upregulated stress response proteins of C. glabrata, for example, HSP 12 and cytoplasmic thioredoxin isoenzyme (Trx1p), are associated with enhanced biofilm formation compared to planktonic cells.

5. Conclusions

Biofilm formation, that is, accumulation of dental plaque, is closely related to upregulated glycolysis or microbial carbohydrate utilization, leading, if uncontrolled or not managed, to the triggered pathological proinflammatory host response. In this regard, oral hygiene and early interventions by removal of accumulating biofilm are essential. Eventually, the current findings indicate that FLJ exerts potential to reduce or even prevent the energy supplies involved in the pathological and excessive biofilm accumulation. This implicates reduced propathogenic potential of biofilm exposed to FLJ.

Bioactive berry compounds are known to cause destabilization of cell membranes of human pathogens [7], causing various antimicrobial effects, for example, depletion of the intracellular ATP pool, inhibition of oxidative phosphorylation, or inhibition of cell wall enzyme activity. Our results demonstrate multiple plausible mechanisms for potential inhibitory effects of fermented FLJ on C. glabrata growth related to changes in the intracellular proteome. Further studies are warranted on the mechanisms of interactions on the cell wall and intracellular level as well as on the inhibition of biofilm growth.


The author Pirjo Pärnänen has filed the patent “a preparation for balancing the oral microbial flora” (EPO 11795242.4). This work was presented in part as a poster at the International Association for Dental Research (XXVIII Reunión Anual de IADR División Chile, Santiago, 9.8.2016) meeting, Abstract no. 120.

Conflicts of Interest

Regarding the funding, the authors declare no conflicts of interest.


This study was supported by Grants TYH2015509, 2016251, and 2014422 from the Research Foundation of Helsinki University Hospital, Helsinki, Finland, the Finnish Dental Society Apollonia, and Karolinska Institutet, Stockholm, Sweden. The LC-MS/MS analyses were made at the Institute of Biotechnology, University of Helsinki.


  1. P. L. Fidel Jr., J. A. Vazquez, and J. D. Sobel, “Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans,” Clinical Microbiology Reviews, vol. 12, no. 1, pp. 80–96, 1999. View at: Google Scholar
  2. C.-Y. Low and C. Rotstein, “Emerging fungal infections in immunocompromised patients,” F1000 Medicine Reports, vol. 3, no. 1, article 14, 2011. View at: Publisher Site | Google Scholar
  3. J.-P. Vermitsky and T. D. Edlind, “Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 10, pp. 3773–3781, 2004. View at: Publisher Site | Google Scholar
  4. C. J. Seneviratne, Y. Wang, L. Jin, Y. Abiko, and L. P. Samaranayake, “Proteomics of drug resistance in Candida glabrata biofilms,” Proteomics, vol. 10, no. 7, pp. 1444–1454, 2010. View at: Publisher Site | Google Scholar
  5. A. Nawaz, P. Pärnänen, K. Kari, and J. H. Meurman, “Proteolytic activity and cytokine up-regulation by non-albicans Candida albicans,” Archives of Microbiology, vol. 197, no. 4, pp. 533–537, 2015. View at: Publisher Site | Google Scholar
  6. P. Pärnänen, J. H. Meurman, and T. Sorsa, “The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2,” Mycoses, vol. 54, no. 4, pp. 325–330, 2011. View at: Publisher Site | Google Scholar
  7. P. Pärnänen, J. H. Meurman, and P. Nikula-Ijäs, “A novel Candida glabrata cell wall associated serine protease,” Biochemical and Biophysical Research Communications, vol. 457, no. 4, pp. 676–680, 2015. View at: Publisher Site | Google Scholar
  8. R. Puupponen-Pimiä, L. Nohynek, H.-L. Alakomi, and K.-M. Oksman-Caldentey, “Bioactive berry compounds—novel tools against human pathogens,” Applied Microbiology and Biotechnology, vol. 67, no. 1, pp. 8–18, 2005. View at: Publisher Site | Google Scholar
  9. R. Puupponen-Pimiä, L. Nohynek, H.-L. Alakomi, and K.-M. Oksman-Caldentey, “The action of berry phenolics against human intestinal pathogens,” BioFactors, vol. 23, no. 4, pp. 243–251, 2005. View at: Publisher Site | Google Scholar
  10. L. J. Nohynek, H.-L. Alakomi, M. P. Kähkönen et al., “Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens,” Nutrition and Cancer, vol. 54, no. 1, pp. 18–32, 2006. View at: Publisher Site | Google Scholar
  11. P. Pärnänen, “A preparation for balancing the oral microbial flora,” EPO 11795242.4. View at: Google Scholar
  12. A. Ullah, M. I. Lopes, S. Brul, and G. J. Smits, “Intracellular pH homeostasis in Candida glabrata in infection-associated conditions,” Microbiology, vol. 159, no. 4, pp. 803–813, 2013. View at: Publisher Site | Google Scholar
  13. M. L. Delgado, J. E. O'Connor, I. Azorín, J. Renau-Piqueras, M. L. Gil, and D. Gozalbo, “The glyceraldehyde-3-phosphate dehydrogenase polypeptides encoded by the Saccharomyces cerevisiae TDH1, TDH2 and TDH3 genes are also cell wall proteins,” Microbiology, vol. 147, no. 2, pp. 411–417, 2001. View at: Publisher Site | Google Scholar
  14. C. V. Loureiro y Penha, P. H. B. Kubitschek, G. Larcher et al., “Proteomic analysis of cytosolic proteins associated with petite mutations in Candida glabrata,” Brazilian Journal of Medical and Biological Research, vol. 43, no. 12, pp. 1203–1214, 2010. View at: Publisher Site | Google Scholar
  15. H. Tükenmez, H. M. Magnussen, M. Kovermann, A. Byström, M. Wolf-Watz, and B. G. Vertessy, “Linkage between fitness of yeast cells and adenylate kinase catalysis,” PLoS ONE, vol. 11, no. 9, Article ID e0163115, 2016. View at: Publisher Site | Google Scholar
  16. J. Ahn, M. Won, J.-H. Choi et al., “Small heat-shock protein Hsp9 has dual functions in stress adaptation and stress-induced G2-M checkpoint regulation via Cdc25 inactivation in Schizosaccharomyces pombe,” Biochemical and Biophysical Research Communications, vol. 417, no. 1, pp. 613–618, 2012. View at: Publisher Site | Google Scholar
  17. H. Kusch, S. Engelmann, D. Albrecht, J. Morschhäuser, and M. Hecker, “Proteomic analysis of the oxidative stress response in Candida albicans,” Proteomics, vol. 7, no. 5, pp. 686–697, 2007. View at: Publisher Site | Google Scholar
  18. C. J. Seneviratne, Y. Wang, L. Jin, Y. Abiko, and L. P. Samaranayake, “Candida albicans biofilm formation is associated with increased anti-oxidative capacities,” Proteomics, vol. 8, no. 14, pp. 2936–2947, 2008. View at: Publisher Site | Google Scholar

Copyright © 2017 Pirjo Pärnänen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.